-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Akebia Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q1 2025.
- Akebia Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $2.19M, a 7.33% decline year-over-year.
- Akebia Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $7.6M, a 17.3% decline year-over-year.
- Akebia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $7.78M, a 16.6% decline from 2023.
- Akebia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $9.32M, a 47.8% decline from 2022.
- Akebia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.8M, a 21.5% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)